RX Global (www.reedexhibitions.com) (RX) today announced that Gaby Appleton has been named as the company’s first Chief Digital Product Officer.

In this newly created role, Gaby will work across the global RX Global business, spanning 22 countries and over 400 events.  She will be responsible for the company’s digital Strategy and Execution and will also lead the RX Digital Community.  Gaby will report to Brian Brittain, Chief Operating Officer and Richard Mortimore, Chief Commercial Officer.

Hugh Jones, CEO of RX Global, said: “At RX, we’re transforming annual events into continual connections, opening up more doors for more customers and in more places, than ever before.  Digital innovation which surrounds and enhances events is becoming mainstream, expected, and valuable. These digital solutions will both enhance and extend the value of the event marketplace. With Gaby’s arrival, our talent, technology and intelligence will be able to grow exponentially which in turn will deliver extraordinary new opportunities for our customers’ businesses.” 

Commenting on the appointment, Brian Brittain, Chief Operating Officer said: “Gaby has extensive experience in transforming businesses and driving digital innovation, most recently on secondment as Product Director for NHS Test and Trace in the UK from one of our sister companies, Elsevier.  This experience will be brought to bear on RX as we continue to build brilliant digital products for all our B2B and B2C events.  With Gaby on board we will be even better placed to delight our customers and visitors through the power of digital as well as face-to-face.”

Commenting on her appointment, Gaby Appleton said: “I am very happy to be joining the RX Global team at such an exciting time in its history.  I’m looking forward to the challenges and opportunities ahead, supporting our people and our fantastic show brands to connect 365 days a year across multiple platforms.  Now more than ever the power of combined face-to-face events and digital must come together to reboot and reconnect communities and sectors around the world, driving growth for all.  I can’t wait to get started.”

About Gaby Appleton

Gaby has extensive experience in digital transformation across multiple categories.  For the past 6 months she has been Product Director for NHS Test and Trace in the UK, where she led the NHS Covid 19 contact tracing app, which was the second-most downloaded free app in the UK in 2020, as well as assisting with building various other digital products to support the fight against Covid.   Prior to her secondment to the NHS, Gaby was Managing Director of Researcher Products at Elsevier where she was responsible for ScienceDirect and Mendeley, global products that help researchers to discover new knowledge, stay up to date, and showcase their work.  Previously, she was Elsevier’s Global Director of Strategy and worked on the digital transformation of their Research and Health businesses.  Before joining Elsevier, Gaby worked at McKinsey management consultants in their climate change practice, and as a brand manager at Procter & Gamble and Sainsbury’s.

Gaby has a first-class degree in Natural Sciences from Cambridge University and in her spare time she plays touch rugby, competing at the World Cup in 2015 and 2019, and in the European Championships in 2017.



For further information, please contact Sarah Kitley-Spencer: 

Email: Sarah.Kitley-Spencer@reedexpo.co.uk  Telephone: ++44 (0)7813 777947.

About RX Global Global

RX Global is a leading global events business. It combines face-to-face with data and digital tools to help customers learn about markets, source products and complete transactions at over 400 events in 22 countries across 43 industry sectors, attracting more than 7 million participants.  Our events leverage industry expertise, large data sets and technology to enable our customers to connect face-to-face or digitally and generate billions of dollars of revenues for the economic development of local markets and national economies around the world.   RX Global is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers.www.reedexhibitions.com

About RELX

RELX is a global provider of information-based analytics and decision tools for professional and business customers. The Group serves customers in more than 180 countries and has offices in about 40 countries. It employs over 33,000 people, of whom almost half are in North America. The shares of RELX PLC, the parent company, are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX.  The market capitalisation is approximately £34.3bn, €40bn, $47.7bn.*

*Note: Current market capitalisation can be found at http://www.relx.com/investors